Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 3KUM2721U9 |
InChI Key | CFMYXEVWODSLAX-QOZOJKKESA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C11H17N3O8 |
Molecular Weight | 319.27 |
AlogP | -5.52 |
Hydrogen Bond Acceptor | 11.0 |
Hydrogen Bond Donor | 8.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 190.25 |
Molecular species | BASE |
Aromatic Rings | 0.0 |
Heavy Atoms | 22.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 4-14 | 2 | - | 79-87 |
Mesh Heading | Maximum Phase | Reference |
---|---|---|
Neuralgia; Peripheral Nervous System Diseases | Phase 2 | ClinicalTrials |
Cancer Pain | Phase 3 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 4368-28-9 |
ChEMBL | CHEMBL507974 |
FDA SRS | 3KUM2721U9 |
Guide to Pharmacology | 2616 |
PDB | 9SR |
PubChem | 11174599 |
SureChEMBL | SCHEMBL6406675 |
ZINC | ZINC000013780673 |